Delivery Order SPE2DB22D3009-SPE2DB24FAP55
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,556.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OxyContin ER 20 mg tablets. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is a for-profit organization. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OxyContin ER 10 mg tablets. The contract has a completion date of January 31, 2024 and a potential value of $1,240.00. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA to the company. The IDC has a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 40 mg Oxycontin ER tablets in 100 count bottles. The contract has a completion date of April 5, 2024 and a ceiling value of $5,065.90. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $4,829.35, is for the delivery of 4,564,053,637 tablets of the pharmaceutical product OxyContin ER 60 mg. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen Drug Corp to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,107.33 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 100 units of OxyContin ER 20 mg tablets and has a completion date of February 7, 2024. Amerisourcebergen Drug Corporation is the prime contractor and serves as a supplier of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,439.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563714186 tablets of OxyContin ER 30 mg. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,436.16 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OxyContin ER 20 mg tablets. This delivery order falls under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,715,826 units of the branded pharmaceutical product OxyContin ER 30 mg tablets in 100-count bottles. The contract has a potential value of $1,043.40 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this delivery order, which is not...
- The Defense Logistics Agency awarded a $2,083.41 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of OxyContin ER 10 mg tablets. The award has a completion date of February 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 from DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,278.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Oxycontin ER 80 mg tablets in 100-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
Teaming
Find teaming partners for this award
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAP55Delivery Order
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,361.63 order is for the supply of 100 tablets of OxyContin ER 20 mg. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities worldwide. This delivery order was not set-aside for any socioeconomic categories.
Generated 5/8/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/7/24 |